Aims: Skin findings are common in patients with both chronic kidney disease and undergoing hemodialysis. These findings are observed as nonspecific and specific dermatological manifestations. Our study aimed to describe the characteristics of dermatologic findings of patients with end-stage renal disease undergoing maintenance hemodialysis treatment and to investigate the relationship between these findings and the demographic and clinical features of those patients.
Methods: Patients who were admitted to a private hemodialysis clinic in August 2023 were prospectively analyzed. Age, gender, type of vascular access, hemodialysis duration, etiology of end-stage renal disease, duration and frequency of hemodialysis sessions, dermatological findings, and the most recent complete blood count, parathyroid hormone, calcium, phosphorus, urea, and creatinine levels were examined and the findings were documented. Calcium x phosphorus levels were calculated. Statistical significance was accepted as p<0.05.
Results: A total of 43 patients with chronic kidney disease undergoing maintenance hemodialysis were included in the study. 23 (53.5%) of the patients were female and 20 (46.5%) were male. The ages of the patients ranged from 28 to 86 years (mean age: 62.79±12.63). Xerosis was the most common dermatological finding with a rate of 90.7%. Hyperpigmentation was found in 46.5%, pruritus in 41.9%, nail disorders (subungual hyperkeratosis, absent lunula, koilonychia, half and half nail, onychorrhexis) in 37.2%, pallor in 30.2% and ecchymosis in 14%. In addition, 55.8% of the patients had mucosal changes (mucosal pallor, xerostomia, oral candidiasis, black hairy tongue, burning mouth), and 27.9% had hair findings (lusterless hair, sparse hair, telogen effluvium). Pruritus was more frequent in patients with higher predialysis urea levels (173.27±49.75 mg/dl vs. 137.04±38.19 mg/dl), (p<0.011). Xerosis and hair findings were more common in women (100% vs. 80%, 92% vs. 0%), (p<0.039, p<0.001). Hyperpigmentation was found more frequently in patients with long-term hemodialysis duration (median: 6.50 years vs. 2.00 years), (p<0.003).
Conclusion: Dermatologic findings are frequently observed in patients under maintenance hemodialysis treatment and may have a negative impact on quality of life. Therefore, dermatologic evaluation should be considered an essential part of treatment in patients under maintenance hemodialysis.
Primary Language | English |
---|---|
Subjects | Dermatology |
Journal Section | Original Article |
Authors | |
Early Pub Date | October 28, 2023 |
Publication Date | October 29, 2023 |
Published in Issue | Year 2023 Volume: 6 Issue: 6 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.